Transporters involved in apical and basolateral uptake of Ceftibuten into Caco-2 cellsMENON, Rajeev M; BARR, William H.Biopharmaceutics & drug disposition. 2002, Vol 23, Num 8, pp 317-326, issn 0142-2782, 10 p.Article

In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibutenPERILLI, M; SEGATORE, B; TAVIO, M et al.Journal of chemotherapy. 2007, Vol 19, Num 2, pp 123-126, issn 1120-009X, 4 p.Article

Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellaeLIVERMORE, David M; MUSHTAQ, Shazad; NGUYEN, Tue et al.International journal of antimicrobial agents (Print). 2011, Vol 37, Num 5, pp 405-409, issn 0924-8579, 5 p.Article

In vitro activity of ceftibuten at sub-inhibitory concentrations in comparison with other antibiotics against respiratory and urinary tract pathogensMAIOLI, E; MARCHESE, A; ROVETA, S et al.Journal of chemotherapy. 2007, Vol 19, Num 2, pp 152-160, issn 1120-009X, 9 p.Article

Ceftibuten : a review of its antibacterial activity, pharmacokinetic properties and clinical efficacyWISEMAN, L. R; BALFOUR, J. A.Drugs (Basel). 1994, Vol 47, Num 5, pp 784-808, issn 0012-6667Article

Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteersNIX, D. E; SYMONDS, W. T; HYATT, J. M et al.Pharmacotherapy. 1997, Vol 17, Num 1, pp 121-125, issn 0277-0008Article

Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitisZIERING, W; MCELVAINE, P.Infection. 1998, Vol 26, Num 1, pp 68-75, issn 0300-8126Article

Ceftibuten: A new expanded-spectrum oral cephalosporinGUAY, D. R. P.The Annals of pharmacotherapy. 1997, Vol 31, Num 9, pp 1022-1033, issn 1060-0280Article

Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten : effect of large inoculaMEDEIROS, A. A; CRELLIN, J.The Pediatric infectious disease journal. 1997, Vol 16, Num 3, pp S49-S55, issn 0891-3668, SUPConference Paper

Empiric antibiotic selection criteria for respiratory infections in pediatric practicePICHICHERO, M. E.The Pediatric infectious disease journal. 1997, Vol 16, Num 3, pp S60-S64, issn 0891-3668, SUPConference Paper

Ceftibuten stability to active-site serine and metallo-β-lactamasesPERILLI, Mariagrazia; SEGATORE, Bernardetta; FRANCESCHINI, Nicola et al.International journal of antimicrobial agents. 2001, Vol 17, Num 1, pp 45-50, issn 0924-8579Article

The penetration of Ceftibuten into the respiratory tractKRUMPE, P; LIN, C.-C; RADWANSKI, E et al.Chest. 1999, Vol 116, Num 2, pp 369-374, issn 0012-3692Article

Isomerization of ceftibuten in aqueous solutionHASHIMOTO, N; HIRANO, K.Journal of pharmaceutical sciences. 1998, Vol 87, Num 9, pp 1091-1096, issn 0022-3549Article

Ceftibuten concentrations in human tonsillar tissueSCAGLIONE, F; PINTUCCI, J. P; DEMARTINI, G et al.European journal of clinical microbiology & infectious diseases (Print). 1996, Vol 15, Num 12, pp 940-943, issn 0934-9723Article

Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN 58 940 methodKLEINKAUF, N; RODLOFF, A. C.Clinical microbiology and infection. 2001, Vol 7, Num 6, pp 326-330, issn 1198-743XArticle

Comparative bioavailability of ceftibuten in capsule and suspension formsLIN, C.-C; AFFRIME, M; RADWANSKI, E et al.Clinical therapeutics. 1996, Vol 18, Num 6, pp 1139-1149, issn 0149-2918Conference Paper

Effects of cefepime, cefixime and ceftibuten on murine gut colonization by Candida albicansMARAKI, S; BARBOUNAKIS, E; CHATZINIKOLAOU, I et al.Chemotherapy (Basel). 1998, Vol 44, Num 6, pp 405-408, issn 0009-3157Article

Comparison of Ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chambersMENON, R. M; BARR, W. H.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 7, pp 299-308, issn 0142-2782, 10 p.Article

Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritisNEUHAUS, Thomas J; BERGER, Christoph; GERVAIX, Alain et al.European journal of pediatrics. 2008, Vol 167, Num 9, pp 1037-1047, issn 0340-6199, 11 p.Article

Increased protein level of PEPT1 intestinal H⁺-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized ratsSHIMIZU, Yuriko; MASUDA, Satohiro; NISHIHARA, Kumiko et al.American journal of physiology. Gastrointestinal and liver physiology. 2005, Vol 51, Num 4, pp G664-G670, issn 0193-1857Article

Clinical evaluation of ceftibuten in gonorrhea : A pilot study in Hong KongLAI YIN CHONG; WAI MAN CHEUNG; CHUN SING LEUNG et al.Sexually transmitted diseases. 1998, Vol 25, Num 9, pp 464-467, issn 0148-5717Article

Epidemiology and treatment of otitis media with effusion in children in the first year of primarv schoolMARCHISIO, P; PRINCIPI, N; DE SANTIS, A et al.Acta oto-laryngologica. 1998, Vol 118, Num 4, pp 557-562, issn 0001-6489Article

The post-exposure response of Enterobacteriaceae to ceftibutenMACKENZIE, F. M; MILNE, K. E; GOULD, I. M et al.Journal of antimicrobial chemotherapy (Print). 1999, Vol 43, Num 1, pp 71-77, issn 0305-7453Article

CeftibutenBHATNAGAR, S; CHANDRA, J.Indian pediatrics. 1999, Vol 36, Num 9, pp 901-904, issn 0019-6061Article

Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in childrenMOOLASART, P; EAMPOKALAP, B; RATANASRITHONG, M et al.Southeast Asian journal of tropical medicine and public health. 1999, Vol 30, Num 4, pp 764-769, issn 0125-1562Article